Microbiome-based therapeutics for metabolic disorders: harnessing microbial intrusions for treatment

微生物群 粪便细菌疗法 殖民抵抗 生物技术 生物 移植 肠道菌群 代谢调节 医学 肠道微生物群 重症监护医学 失调 代谢途径 抗生素耐药性 抗生素 益生菌 生物信息学
作者
Nafees Ahmed,Vishwas Gaur,Madhu Kamle,Abhishek Chauhan,Ritu Chauhan,Pradeep Kumar,Namita Ashish Singh
出处
期刊:Frontiers in medical technology [Frontiers Media]
卷期号:7: 1695329-1695329 被引量:19
标识
DOI:10.3389/fmedt.2025.1695329
摘要

The rising global rates of metabolic disorders, such as obesity, type 2 diabetes, non-alcoholic fatty liver disease, and metabolic syndrome, call for new treatment methods beyond traditional drugs. The human gut microbiota, made up of trillions of microorganisms that plays a crucial role in maintaining metabolic balance through complex biochemical processes and interactions between hosts and microbes. Dysbiosis, which involves changes in microbial composition and a decrease in diversity, has become a major factor in metabolic problems. This disruption impacts the production of short-chain fatty acid, increase in permeability of intestine, and causes enduring low-grade inflammation. This review features into the potential of treatments based on microbiome for metabolic syndromes, focusing on probiotics, prebiotics, synbiotics, and postbiotics. It also encompasses innovative methods such as engineered microbial consortium, fecal microbiota transplantation (FMT), and vaginal microbiota transplantation (VMT). Probiotics show significant promise in improving blood sugar control and enhancing lipid levels. Prebiotics help bring about positive changes in microbial composition and the production of beneficial metabolites. Synbiotic combinations provide added benefits by helping good microbes thrive while supplying nutrients they can ferment. Postbiotics have recent research focus because they are safer, more stable, easier to store, and less likely to contribute to antibiotic resistance comparative to live probiotics. Even now there are substantial complications in translating microbiome research into standardized therapeutics despite of promising pre-clinical outcomes and some initial clinical data. These comprises individual variances, strain-specificity, dosage problems, regulation issues, and the necessity for personalised treatment strategies. Future success will depend upon personalized medicine, technological developments, and the incorporation of multi-omics strategy to generate metabolic health therapeutics depending on targeted microbiomes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
cxhm完成签到,获得积分10
刚刚
李博宇完成签到,获得积分10
刚刚
李国涛发布了新的文献求助10
刚刚
风趣的胜完成签到,获得积分10
刚刚
慕青的应助被无雨采纳,获得10
1秒前
1秒前
1秒前
znn发布了新的文献求助10
1秒前
1秒前
zhang关注了科研通微信公众号
1秒前
Vivi发布了新的文献求助10
2秒前
2秒前
2秒前
吴一斤完成签到,获得积分10
3秒前
小二郎的应助被江江采纳,获得20
3秒前
桐桐的应助被烹全鱼宴采纳,获得10
3秒前
心房的锁完成签到,获得积分10
3秒前
3秒前
ABCD完成签到 ,获得积分10
3秒前
Wendy完成签到,获得积分10
4秒前
4秒前
Orange的应助被www采纳,获得10
4秒前
5秒前
斯文败类的应助被风笛采纳,获得10
5秒前
5秒前
5秒前
dd发布了新的文献求助10
5秒前
5秒前
ZM发布了新的文献求助10
5秒前
5秒前
双儿完成签到,获得积分10
6秒前
luiii发布了新的文献求助30
6秒前
jianglai发布了新的文献求助10
7秒前
7秒前
一生所爱发布了新的文献求助10
7秒前
辰辰发布了新的文献求助10
8秒前
penglinhua完成签到,获得积分20
8秒前
牛C小超人发布了新的文献求助10
9秒前
znn完成签到,获得积分10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181279
求助须知:如何正确求助?哪些是违规求助? 9571198
关于积分的说明 21817073
捐赠科研通 7777612
什么是DOI,文献DOI怎么找? 3433454
关于科研通互助平台的介绍 2557692
邀请新用户注册赠送积分活动 2479519